Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with GlaxoSmithKline’s range of Ellipta dry powder inhalers.
The ASX-listed firm offers the Hailie sensor which attaches to an inhaler to remotely monitor and capture medication usage parameters and...
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.
The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group.
The device connects to a...
Alphabet serious about health wearables? Alphabet has reportedly put in an unspecified offer to buy out Fitbit, according to anonymous sources talking to Reuters. The news comes roughly a month after another report from the outlet suggesting that the wearables maker had brought on investment firm Qatalyst Partners to explore a potential sale, in which Alphabet was name dropped as a potential...
While recent news of international product launches and recent M&As might suggest a cutthroat market, new data released this week by Research2Guidance suggest that there is still plenty of room in the digital respiratory health sector for both existing and new market players.
According to “The Global Digital Respiratory Solutions Market 2009-2023” report, roughly 210 million asthma and COPD...
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence.
Following an unspecified investment in the...
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.
“We’ve had a great relationship over the last couple of years with AstraZeneca, we’ve launched in a couple dozen countries now...
London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding. The amount was not disclosed. Sanner Ventures and Breed Reply (a previous investor) led the round.
Amiko Digital Health’s flagship product, Respiro, consists of two parts. The first part is a connected inhaler for respiratory disease patients, which measures compliance, lung...
Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile health tools can be used to manage asthma.
Adherium’s Smartinhaler technology, which uses sensors to track when medication is taken and then sends the data via Bluetooth to mobile devices...
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler.
This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
Madison, Wisconsin-based Propeller Health has closed a $21.5 million Series C financing round, with new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, plus existing investors Safeguard Scientifics and Social Capital. The funding will be used to further Propeller’s digitally-guided therapy platform.
Propeller’s aim is to simplify management of chronic respiratory diseases like asthma...
